Discontinued — last reported Q4 '25
Investing
Acquisitions
Cintas Acquisitions decreased by 89.0% to $9.45M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 78.5%, from $43.92M to $9.45M. Over 3 years (FY 2022 to FY 2025), Acquisitions shows an upward trend with a 12.4% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
Detailed definition
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Peer comparison
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
Metric ID:
cf_acquisitionsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.73M | $9.95M | $105.17M | $13.38M | $7.06M | $8.40M | $17.53M | $13.37M | $55.65M | $18.35M | $111.03M | $1.81M | $9.44M | $145.45M | $43.92M | $34.09M | $7.60M | $85.63M | $9.45M |
| QoQ Change | — | -72.2% | +957.6% | -87.3% | -47.3% | +18.9% | +108.7% | -23.7% | +316.1% | -67.0% | +505.2% | -98.4% | +421.6% | >999% | -69.8% | -22.4% | -77.7% | >999% | -89.0% |
| YoY Change | — | — | — | — | -80.2% | -15.6% | -83.3% | -0.1% | +688.3% | +118.5% | +533.5% | -86.5% | -83.0% | +692.8% | -60.4% | >999% | -19.4% | -41.1% | -78.5% |
Range$1.81M – $145.45M
CAGR-25.6%
Avg YoY Growth+218.0%
Median YoY Growth-19.4%
Acquisitions at Other Companies
Frequently Asked Questions
- What is Cintas's acquisitions?
- Cintas (CTAS) reported acquisitions of $9.45M in Q4 2025.
- How has Cintas's acquisitions changed year-over-year?
- Cintas's acquisitions decreased by 78.5% year-over-year, from $43.92M to $9.45M.
- What is the long-term trend for Cintas's acquisitions?
- Over 3 years (2022 to 2025), Cintas's acquisitions has grown at a 12.4% compound annual growth rate (CAGR), from $164.23M to $232.90M.
- What does acquisitions mean?
- Cash spent to acquire other companies or businesses, net of cash received in the deal.